Effects of dietary supplementation with an expressed fusion peptide bovine lactoferricin-lactoferrampin on performance, immune function and intestinal mucosal morphology in piglets weaned at age 21 d

British Journal of Nutrition

Volumn 101, Issue 7, 2009, Pages 998-1005

  Tang, Zhiru ^a   Yin, Yulong ^a   Zhang, Youming ^a   Huang, Ruilin ^a   Sun, Zhihong ^a   Li, Tiejun ^a   Chu, Wuying ^a   Kong, Xiangfeng ^a   Li, Lili ^a   Geng, Meimei ^a   Tu, Qiang ^a  

^a INSTITUTE OF GEOLOGY AND GEOPHYSICS   (China)

Author keywords

Bovine lactoferricin lactoferrampin; Growth performance; Gut flora; Immune function; Weaned piglets

Indexed keywords

COLISTIN; GLUTATHIONE PEROXIDASE; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; LACTOFERRAMPIN; LACTOFERRICIN; LACTOFERRICIN LACTOFERRAMPIN FUSION PROTEIN; PEROXIDASE; POLYPEPTIDE ANTIBIOTIC AGENT; PROTEIN CIPB; SUPEROXIDE DISMUTASE; UNCLASSIFIED DRUG; ANTIINFECTIVE AGENT; ANTIOXIDANT; BACTERIAL PROTEIN; CIPB PROTEIN, PHOTORHABDUS LUMINESCENS; LACTOFERRICIN B; LACTOFERRIN; LACTOGLOBULIN; PEPTIDE FRAGMENT; RECOMBINANT PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBACTERIAL ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; BIFIDOBACTERIUM; BODY GROWTH; CECUM; COLON; CONTROLLED STUDY; DIARRHEA; DIET SUPPLEMENTATION; ENTEROTOXIGENIC ESCHERICHIA COLI; ILEUM; IMMUNE RESPONSE; IMMUNOGLOBULIN BLOOD LEVEL; INTESTINE FUNCTION; INTESTINE MUCOSA; INTESTINE VILLUS; IRON BINDING CAPACITY; LACTOBACILLUS; NONHUMAN; PHOTORHABDUS LUMINESCENS; PIGLET; SOYBEAN; TEST MEAL; WEANING; WEIGHT GAIN; ANIMAL; ANIMAL FOOD; CATTLE; CHEMISTRY; COMPARATIVE STUDY; ESCHERICHIA COLI INFECTION; GENETIC ENGINEERING; GENETICS; IMMUNOLOGY; LIVER; MALE; MICROBIOLOGY; PATHOLOGY; RANDOMIZATION; SWINE; SWINE DISEASE;

BOVINAE; ESCHERICHIA COLI; PHOTORHABDUS LUMINESCENS; SUIDAE; ZEA MAYS;

ANIMAL FEED; ANIMALS; ANTI-BACTERIAL AGENTS; ANTIOXIDANTS; BACTERIAL PROTEINS; CATTLE; COLISTIN; DIARRHEA; DIETARY SUPPLEMENTS; ENTEROTOXIGENIC ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; GENETIC ENGINEERING; INTESTINAL MUCOSA; LACTOFERRIN; LACTOGLOBULINS; LIVER; MALE; PEPTIDE FRAGMENTS; RANDOM ALLOCATION; RECOMBINANT PROTEINS; SWINE; SWINE DISEASES; WEANING;

EID: 67449096940     PISSN: 00071145     EISSN: 14752662     Source Type: Journal    
DOI: 10.1017/S0007114508055633     Document Type: Article

References (51)

1. Pluske JR, Hampson DJ & Williams IH (1997) Factors influencing the structure and function of the small intestine in the weaned pig: A review. Livest Prod Sci 51, 215-236.
2. Hopwood DE, Pluske JR & Hampson DJ (2005) Dietary manipulation of infectious bowel disease. In Biology of Nutrition in Growing Animals pp. 365-385 [R Mosenthin, J Zentek and T Zebrowska, editors]. Amsterdam: Elsevier Ltd.
3. Radostits OM, Leslie KE & Fetrow J (1994) Planned animal health and production in swine herds. In Herd Health. Food Animal Production Medicine, 2nd ed., pp. 435-526 [OM Radostits, editor]. London: Saunders.
4. Davis ME, Brown DC, Baker A, Bos K, Dirain MS, Halbrook E, Johnson ZB, Maxwell C & Rehberger T (2007) Effect of direct-fed microbial and antibiotic supplementation on gastrointestinal microflora, mucin histochemical characterization, and immune populations of weanling pigs. Livest Sci 108, 249-253.
5. Bellamy W, Takase M, Yamauchi K, Wakabayashi H, Kawase K & Tomita M (1992) Identification of the bactericidal domain of lactoferrin. Biochim Biophys Acta 1121, 130-136.
6. Kuwata H, Yip TT, Tomita M & Hutchens TW (1998) Direct evidence of the generation in human stomach of an antimicrobial peptide domain (lactoferricin) from ingested lactoferrin. Biochim Biophys Acta 1429, 129-141.
7. Kuwata H, Yip TT, Yamauchi K, Teraguchi S, Hayasawa H & Tomita M (1998) The survival of ingested lactoferrin in the gastrointestinal tract of adult mice. J Biochem 334, 321-323.
8. Bellamy W, Takase M, Wakabayashi H, Kawase K & Tomita M (1992) Antibacterial spectrum of lactoferricin B, a potent bactericidal peptide derived from the N-terminal region of bovine lactoferrin. J Appl Bacteriol 73, 472-479.
9. Hwang PM, Zhou N, Shan X, Arrowsmith CH & Vogel HJ (1998) Three-dimensional solution structure of lactoferricin B, an antimicrobial peptide derived from bovine lactoferrin. Biochemistry 37, 4288-4298.
10. Tomita M, Takase M, Bellamy W & Shimamura S (1994) A review: The active peptide of lactoferrin. Acta Paediatr Jpn 36, 585-591.
11. Groenink J, Walgreen-Weterings E, van't Hof W, Veerman ECI & Nieuw AAV (1999) Cationic amphipathic peptides, derived from bovine and human lactoferrins, with antimicrobial activity against oral pathogens. FEMS Microbiol Lett 179, 217-222.
12. Wakabayashi H, Matsumoto H, Hashimoto K, Teraguchi S, Takase M & Hayasawa H (1999) N-acylated and d enantiomer derivatives of a nonamer core peptide of lactoferricin B showing improved antimicrobial activity. Antimicrob Agents Chemother 43, 1267-1269.
13. Yoo YC, Watanabe S, Watanabe R, Hata K, Shimazaki K & Azuma I (1997) Bovine lactoferrin and lactoferricin, a peptide derived from bovine lactoferrin, inhibit tumor metastasis in mice. Jpn J Cancer Res 88, 184-190.
14. Bellamy WR, Wakabayashi H, Takase M, Shimamura S & Tomita M (1993) Role of cell-binding in the antibacterial mechanism of lactoferricin B. J Appl Microbiol 75, 478-484.
15. Wakabayashi H, Hiratani T, Uchida K & Yamaguchi H (1996) Antifungal spectrum and fungicidal mechanism of an N-terminal peptide of bovine lactoferrin. J Infect Chemother 1, 185-189.
16. Valenti P, Antonini G, Siciliano R, Rega B, Superti F, Marchetti M, Ammendolia MG & Seganti L (2000) Antiviral activity of lactoferrin derived peptides. In Lactoferrin: Structure, Function and Applications, pp. 181-186 [K Shimazaki, H Tsuda, M Tomita, T Kuwata and JP Perraudin, editors]. New York: Elsevier Publishing.
17. Andersen JH, Osbakk SA, Vorland LH, Traavik T & Gutteberg TJ (2001) Lactoferrin and cyclic lactoferricin inhibit the entry of human cytomegalovirus into human fibroblasts. Antiviral Res 51, 141-149.
18. Iigo M, Kuhara T, Ushida Y, Sekine K, Moore MA & Tsuda H (1999) Inhibitory effects of bovine lactoferrin on colon carcinoma 26 lung metastasis in mice. Clin Exp Metastasis 17, 35-40.
19. Brock J (1995) Lactoferrin: A multifunctional immunoregulatory protein? Immunol Today 16, 417-419.
20. Levay PF & Viljoen M (1995) Lactoferrin: A general review. Haematologica 80, 252-267.
21. Marieke IA, van der K, Jasper G, Kamran N, Enno CIV, Jan GMB & Arie VNA (2004) Lactoferrampin: A novel antimicrobial peptide in the N1-domain of bovine lactoferrin. Peptides 25, 177-183.
22. van der Kraan MI, Nazmi K, van't Hof W, Amerongen AV, Veerman EC & Bolscher JG (2006) Distinct bactericidal activities of bovine lactoferrin peptides LFampin 268-284 and LFampin 265-284: Asp-Leu-Ile makes a difference. Biochem Cell Biol 84, 358-362.
23. Tang ZR, (2007) Study on expression of bovine lactoferricin-lactoferrampin in Photorhabdus luminescens and its mechanism of action. PhD Thesis, Institute of Subtropical Agriculture, the Chinese Academy of Sciences, Changsha, Hunan Province, China.
24. Montagne L, Cavaney FS, Hampson DJ, Lallès JP & Pluske JR (2004) Effect of diet composition on postweaning colibacillosis in piglets. J Anim Sci 82, 2364-2374.
25. Tang ZR, Yin YL, Nyachoti CN, et al. (2005) Effect of dietary supplementation of chitosan and galacto-mannan-oligosaccharide on serum parameters and the insulin-like growth factor-I mRNA expression in early-weaned piglets. Domest Anim Endocrinol 28, 430-441.
26. National Research Council (1998) Nutrient Requirements of Swine, 10th revised ed. Washington, DC: National Academic Press.
27. Namkung H, Gong J, Yu H & de Lange CFM (2006) Effect of pharmacological intakes of zinc and copper on growth performance, circulating cytokines and gut microbiota of newly weaned piglets challenged with coliform lipopolysaccharides. Can J Anim Sci 86, 511-522.
28. McManus JFA (1946) Histological demonstration of mucin after periodic acid. Nature 158, 202-205.
29. Kik M, Huisman JL & van der Poel AFB (1990) Pathologic changes of the small intestinal mucosa of pigs after feeding Phaseolus vulgaris beans. Vet Pathol 27, 329-334.
30. Callesen J, Halas D, Thorup F, Bach KKE, Kim JC, Mullan BP, Hampson DJ, Wilson RH & Pluske JR (2007) The effects of weaning age, diet composition, and categorisation of creep feed intake by piglets on diarrhoea and performance after weaning. Livest Sci 108, 120-123.
31. Arnold RR, Cole MF & McGhee JR (1977) A bactericidal effect for human lactoferrin. Science 197, 263-265.
32. Ellison RT, Giehl TJ & Laforce FM (1988) Damage of the outer membrane of gram-negative bacteria by lactoferrin and transferrin. Infect Immun 56, 2774-2781.
33. Ulvatne H, Haukland HH, Olsvik O & Vorland LH (2001) Lactoferricin B causes depolarization of the cytoplasmic membrane of Escherichia coli ATCC 25922 and fusion of negatively charged liposomes. FEBS Lett 492, 62-65.
34. Mann DM, Romm E & Migliorini M (1994) Delineation of glycosaminoglycan-binding site in human inflammatory response protein lactoferrin. J Biol Chem 269, 23661-23667.
35. Elass-Rochard E, Roseanu A, Legrand D, Trif M, Salmon V, Motas C, Montreuil J & Spik G (1995) Lactoferrin-lipopolysaccharide interaction: involvement of the 28-34 loop region of human lactoferrin in the high-affinity binding to Escherichia coli 055B5 lipopolysaccharide. J Biochem 312, 839-845.
36. Nikaido H & Nakae T (1979) The outer membrane of Gram-negative bacteria. Adv Microb Physiol 20, 163-250.
37. Humphrey BD, Huang N & Klasing KC (2002) Rice expressing lactoferrin and lysozyme has antibiotic-like properties when fed to chicks. J Nutr 132, 1214-1218.
38. Swidsinski A, Ladhoff A, Pernthaler A, et al. (2002) Mucosal flora in inflammatory bowel disease. Gastroenterology 122, 44-54.
39. Gislason J, Iyer S, Hutchens TW & Lonnerdal B (1993) Lactoferrin receptors in piglet small intestine: Lactoferrin binding properties, ontogeny, and regional distribution in the gastrointestinal tract. J Nutr Biochem 4, 528-533.
40. Alessia F, Paola I & Alessandro S (2007) Zinc, antioxidant systems and metallothionein in metal-mediated apoptosis: Biochemical and cytochemical aspects. Comp Biochem Physiol C 146, 443-459.
41. Sies H (1993) Strategies of antioxidant defense. Eur J Biochem 215, 213-219.
42. Lindmark-Månsson H & Åkesson B (2000) Antioxidative factors in milk. Br J Nutr 84, Suppl. 1, S103-S110.
43. Bihel S & Birlouez-Aragon I (1998) Inhibition of tryptophan oxidation in the presence of iron-vitamin C by bovine lactoferrin. Int Dairy J 8, 637-641.
44. Bruininx EM, van der Peet-Schwering CM, Schrama JW, Vereijken PF, Vesseur PC, Everts H, den Hartog LA & Beynen AC (2001) Individually measured feed intake characteristics and growth performance of group-housed weanling pigs: Effects of sex, initial body weight, and body weight distribution within groups. J Anim Sci 79, 301-308.
45. Debbabi H, Dubarry M, Rautureau M & Tomé D (1998) Bovine lactoferrin induces both mucosal and systemic immune response in mice. J Dairy Res 65, 283-293.
46. Prgomet C, Prenner ML, Schwarz FJ & Pfaffl MW (2007) Effect of lactoferrin on selected immune system parameters and the gastrointestinal morphology in growing calves. J Anim Physiol Anim Nutr 91, 109-119.
47. Shu Q, Qu F & Gill HS (2001) Probiotic treatment using Bifidobacterium lactis HN019 reduces weanling diarrhea associated with rotavirus and Escherichia coli infection in a piglet model. J Pediatr Gastroenterol Nutr 33, 171-177.
48. Trif M, Guillen C, Vaughan DM, Elfer TJM, Brewer JM, Roseanu A & Brock JH (2001) Liposomes as possible carriers for lactoferrin in the local treatment of inflammatory diseases. Exp Biol Med 226, 559-564.
49. Bavaye S, Elass E, Mazurier J, Spik G & Legrand D (1999) Lactoferrin: A multifunctional glycoprotein involved in the modulation of the inflammatory process. Clin Chem Lab Med 37, 281-286.
50. Adamik B & Walszczyk A (1996) Lactoferrin: Its role in defence against infection and immunotropic properties (article in Polish). Postepy Hig Med Dosw 50, 33-41.
51. Lonnerdal B & Iyer S (1995) Lactoferrin: Molecular structure and biological function. Annu Rev Nutr 15, 93-110.